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Abstract 
Objectives: The objective of this study was to explore the conformity of online sites with established quality standards.  
Methods: Online pharmacies with the NABP Verified Internet Pharmacy Practice Sites (VIPPS) designation were scrutinized for their 
conformity with select criteria established by the National Association of Board of Pharmacies (NABP) and FDA consumer guidelines.  
Results: 36 VIPPS certified online pharmacy sites were included in the study. The sites were examined against VIPPS and FDA 
standards. The criteria related to the design and content of the web site and to the pharmaceutical services being offered through 
the site. Lack of clear terminological distinction between “online pharmacy” (a business) and “online site” (a tool for a business) was 
problematic. Sites did not adhere to uniform design principles. The scope and availability of pharmaceutical services for online 
consumers were not readily apparent. 
Conclusion: The very legitimacy of existing criteria for online pharmacies remains to be established. Significant opportunities exist to 
improve the quality and scope of policies and to tie them more closely to longstanding best-practices in areas such as web usability 
and pharmaceutical care. Revision recommendations for VIPPS criteria are discussed.  
 
 
Introduction 
Technology-enabled services have become the bedrock of 
innovative healthcare and product delivery models. 
Decreasing cost of technology is allowing companies to 
satiate growing consumer appetite for convenient, just-in-
time, and customized products. In this new era, the online 
marketplace for pharmaceutical care and pharmaceutics has 
proven to be particularly vast, transnational, and ever 
expanding. As compared to the traditional brick-and-mortar 
shopping experience, the online marketplace offers 
consumers superior convenience, ability to comparison shop 
for prices, and anonymity.1  
 
Despite their monumental growth over the last two decades, 
however, online pharmacies remain sparsely regulated.2 The 
lack of policies and mechanisms to ensure product quality 
and safety is especially troubling for pharmacies operating 
exclusively or largely via an online presence.3,4 Since their 
gain in popularity in the early 1990s, ensuring the legitimacy 
of such pharmacies has been a daunting task, thus hampering 
the fulfillment of a promise for innovative online service 
delivery and product procurement options. 
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For consumers, ensuring the legitimacy of an online 
pharmacy is complicated primarily by resource limitations; 
limited health literacy and technological savvy preclude 
would-be users from discerning online pharmacies with safe 
products and services. Various agencies in the United States 
offer guidance to consumers in choosing online pharmacies 
and go so far as to certify vendors as being compliant with 
predetermined sets of criteria. Commercial services such as 
LegitScript and PharmacyChecker add further complexity to 
attempts at verification, a process that is yet to be uniformly 
defined and communicated to stakeholders.  
 
While numerous criteria for online pharmacies have been 
proposed, no systematic attempt has been made to assess 
the validity of such standards. Furthermore, the impact of 
quality criteria on consumer decision-making remains to be 
established. In other words, the very legitimacy of the 
legitimacy criteria remains suspect at this time. 
 
Objective 
The objective of this study was to explore the conformity of 
online pharmacies with existing quality criteria. To establish 
best-of-breed practices, only online pharmacies on the 
National Association of Board of Pharmacies’ (NABP) list of 
Verified Internet Pharmacy Practice Sites (VIPPS) were 
included in the study group.  
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Methods 
Names and Uniform Resource Locators (URLs) of NABP-
certified Internet pharmacies were obtained from the publicly 
available NABP database.5 As of December 23, 2014, the list 
included 46 sites operated by 39 registrants (ranging from 1 
site to 5 sites per registrant). Attempts were made to access 
the sites on December 31, 2014 using Firefox browser, 
version 34.0.5. Member-only sites (n=9) and broken links 
(n=1) were eliminated from consideration, yielding a final 
sample size of 36. 
 
Existing legitimacy considerations were compiled from 
NABP’s Verified Internet Pharmacy Practice Sites (VIPPS) 
criteria and the FDA consumer guidance document for online 
pharmacies. 6 7 We identified six criteria that consumers are 
urged to consider in choosing online pharmacies [Table 1].  
 
Using said criteria, the first author created a codebook to 
standardize the examination of the sites and trained the 
second author on its use. The two researchers then tested 
out the codebook in exploring the first two pharmacies on 
the VIPPS list independently. Pursuant to a discussion of 
initial results, the codebook was modified for clarity. Where 
the codebook called for locating information on the site, we 
limited our attempts to navigating no more than 3 layers 
deep, inclusive of the entry page as linked from the VIPPS 
site.  
 
For the initial review, the authors coded the Internet 
pharmacy sites (n=36) independently. The resulting codes 
were then compared and discussed with the goal of reaching 
consensus. Both authors took equal responsibility in the 
collection and analysis of data, and in preparation of the final 
manuscript. 
 
The study protocol calls for use of no personal information or 
human participation and was deemed as exempt from IRB 
review. 
 
Results 
Both the VIPPS criteria and the FDA consumer guidance use 
the terms “online pharmacy” (i.e., a service entity) and 
“online site” (i.e., the web site for a service entity) rather 
interchangeably. Upon examination of the NABP-provided 
links to VIPPS certified sites, we found the term online 
pharmacy to refer to four types of online sites: 1) sites 
associated with exclusively Internet-based or mail order 
pharmacies; 2) sites associated with primarily store-based 
retail pharmacies, 3) sites associated with freestanding or 
independent pharmacies, and 4) sites with unclear 
associations [Table 2: Types of online sites].  
 
Criteria related to web sites 
Of the 36 VIPPS-accredited pharmacies included in our study, 
26 sites (72%) displayed the VIPPS seal. No sites in our sample 
mentioned compliance with FDA consumer guidelines for 
online pharmacies. In the case of online sites associated with 
a brick-and-mortar entity (n=20; 56%), the NABP offered no 
direct URL link to the pharmacy portion of the operation; 
users need to go initially through the online site for the brick-
and-mortar operation – typically a grocery store site - to 
locate the URL for the online pharmacy (see, for example, 
www.walmart.com). We did notice, however, a tendency for 
such corporate sites to drop browser cookies on the user 
computer which, upon subsequent visits, redirect the user to 
the last page visited. Depending on user navigation pattern, 
the last page visited may or may not have been one 
associated with the pharmacy department. 
 
Privacy policies  
Providing users with a privacy policy is among the VIPPS 
criteria for certification. We identified a small number of 
certified sites (n=3; 8%) that failed to meet this criterion. 
Additional policies displayed online included terms of use; 
patient bill of rights; return policy; web use; and medical 
information privacy. It was common for policy documents 
with similar titles to have dissimilar content and scope. For 
online sites associated with brick-and-mortar stores, the 
policies displayed were not uniformly tailored for pharmacy 
services or pharmaceutical products. For instance, one site 
for a retail pharmacy included return policies for perishable 
food items. 
 
Accurate U.S. address 
VIPPS criteria include that “the pharmacy must provide on 
the website an accurate U.S. address of the dispensing 
pharmacy or corporate headquarters.” Similarly, FDA 
guidance to consumers is to seek sites that provide a physical 
address and telephone number in the United States. Online 
sites associated with multiple physical locations displayed 
addresses for all of their land-based operations. However, 
guidance for which location to choose in the event of a need 
to communicate via postal mail was not uniformly available. 
 
Online sites associated with retail chains (n=13) tended to 
have a “store locator” feature. In such instances, it was not 
uniformly clear whether the consumer would be able to 
locate a pharmacy at said location or was being directed to a 
generic postal address for a retail store. 
 
Web site transparency 
VIPPS criteria state that “the pharmacy must not engage in 
practices or extend offers on its website that may deceive or 
defraud patients as to any material detail regarding the 
Original Research POLICY 
 
http://z.umn.edu/INNOVATIONS                      2015, Vol. 6, No. 3, Article 212                          INNOVATIONS in pharmacy   3 
 
pharmacy, pharmacy staff, prescription drugs, or financial 
transactions.” Our study did not focus extensively on this 
criterion due to the logistical impossibility of verifying and 
confirming claims based solely on information offered on the 
web sites. We did, however, make an attempt to verify claims 
where possible. We noted at least two occasions when a 
pharmacy web site appeared to be making a false claim. On 
one occasion, the pharmacy site referenced a national study 
to support the claim that customer satisfaction is highest 
among users of online pharmacies as compared to local and 
mail-order pharmacies. Upon review of the said study, we 
determined the opposite to be the conclusion of the authors, 
and that satisfaction is the lowest among online pharmacy 
users.8 On another occasion, an online pharmacy claimed to 
have been the first to have achieved the NABP Durable 
Medical Equipment, Prosthetics, Orthotics, and Supplies 
(DMEPOS) accreditation. Closer examination of the NABP 
DMEPOS database available online revealed a number of 
pharmacies with, indeed, earlier accreditation dates. 9 
 
Criteria related to patient services 
The concept of “patient services” through online sites was ill-
defined. The provision and scope of pharmaceutical services 
appeared to differ for consumers seeking such services 
exclusively online or at physical locations. For instance, one 
site claimed that information on the pharmacy website “is 
provided for informational purposes only and is not meant to 
substitute for advice provided by a licensed physician or 
other medical professional,” while another sites claimed that 
“any information supplied through the web site by any 
employee or agent of [company], whether by telephone, e-
mail, letter, facsimile or other form of communication, is for 
educational purposes or general guidance, and does not 
constitute medical, legal, or professional advice.”  
 
For chain pharmacies with online presence, it was not 
consistently clear whether the services displayed online could 
be procured directly from the online pharmacy. Based on the 
information provided, we could not discern whether listed 
services were merely informational in nature whereby their 
procurement would require the consumer to actually interact 
with a local, store-based pharmacist. Adding further to the 
lack of clarity around scope of service, only 13 pharmacies 
(36%) offered information on states they were licensed in or 
could ship to. 
 
Online pharmacies tended to encourage consumers to seek 
direct consultation with a pharmacist rather than rely on 
static, generic information on their web sites. However, only 
a limited number (n=7; 19%) offered clear instructions for 
patient access to pharmacists or other qualified healthcare 
professionals. Where a telephone number or email address 
was provided, it was not consistently clear whether the 
consumer would be connected to a customer service 
representative or to an actual healthcare provider. 
 
All online pharmacies in the study group were found to offer 
educational materials. Rather than offering authentic 
information or resources, however, some online pharmacy 
sites redirected users to sites associated with other, non-
NABP certified URLs (e.g., Mayo Clinic). We also noted 
instances of outdated information. For example, an online 
pharmacy site informed patients that “open enrollment for 
[the Affordable Care Act] begins October 1, 2013” – a date 
clearly in the past at the time of our study. 
 
Discussion 
Consumers are urged to exercise diligence in choosing online 
vendors of repute. However, the availability of validated and 
reliable criteria to guide consumer choices lags significantly 
behind the rate of proliferation of online pharmacies. Even 
sites that are certified by national accreditation bodies do 
not, on initial examination, uniformly make their legitimacy 
apparent to potential users. The criteria offered do not 
differentiate among “a pharmacy” versus “a web site for a 
pharmacy”. Furthermore, what little guidance does exists, it 
is not nuanced enough to acknowledge or accommodate 
potential differences among different types of pharmacy 
operations.  
 
The term “online pharmacy” is difficult to define in practice. 
Whether an “online site” equates, by definition, to an “online 
pharmacy” is not clear.  The ambiguities of definition beg the 
question; does the certification apply to the online site or a 
business with an online presence? As we attempted to apply 
the criteria to sites presumably already in compliance, we 
became aware of the uncertainty of whether the NABP list 
referred to “certified online pharmacies” or, perhaps more 
accurately, to “certified online presence for pharmacies.” 
There is a blurred line between Internet sites for exclusively 
Internet-based pharmacies (e.g., 
www.healthwarehouse.com) and Internet sites for 
traditionally mail-order or store-based pharmacies (e.g., 
www.cvs.com). Furthermore, some Internet pharmacies (e.g., 
www.allcarepharmacy.com) can be classified as either 
“specialty pharmacies with an online presence” or “mail-
order pharmacies with an online presence”. While the 
distinction may be subtle, the failure to define an “online 
pharmacy” vis a vis an “online site” represents a significant 
hurdle to the consistent and meaningful application of 
criteria to ensure provider legitimacy. 
 
The credibility and recognition of VIPPS certification among 
consumers remains to be established. There may be a need 
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for NABP to more widely educate patients and push for more 
aggressive name recognition. As a step toward such 
awareness, NABP should consider mandating VIPPS-certified 
sites to display the VIPPS logo. To ascertain currency of 
accreditation, certified pharmacies should disclose “last 
certified by VIPPS” and “certification expires by” dates. For 
the convenience of the user, NABP should provide links 
directly to the appropriate pharmacy page rather than to 
general entry portals for retail stores. 
 
VIPPS certification is an optional, fee-based service of the 
National Association of Boards of Pharmacy. At the time of 
the writing of this article, fees for initial application ranged 
from $5,000 for independent pharmacies to $8,000 for chain 
and HMO-based pharmacies. This fee structure may be 
prohibitive for smaller operations to justify investing in this 
optional certification. It is our recommendation that VIPPS 
certification becomes a mandatory element for entities 
wishing to operate online. Mandatory certification would 
render the application fee a usual cost of operation across all 
pharmacies. Mandatory certification is also likely to improve 
the quality of online pharmacies in general. The increased 
volume may have the added benefit of lowering NABP’s cost 
of offering the certification service. 
 
Poorly designed web sites weaken the credibility of the VIPPS 
accreditation designation (see, for instance, 
www.drugsdepot.com). VIPPS criteria should include 
guidelines for web site design with an eye toward 
accessibility, usability, and overall design quality. Incomplete 
sentences, typos or incomplete references detract from the 
legitimacy of online pharmacy sites. For instance, the claim 
on a pharmacy site that “[t]his includes at least one prior in-
person medical evaluation or medical evaluation via 
telemedicine in accordance with applicable requirements of 
section 309” is not clear immediately as to what regulation is 
being referenced.  
 
While it was not the aim of our study, we have noted distinct 
differences in quality of web site design between types of 
pharmacies; exclusively online pharmacies as a group have 
superior web sites with easier navigation, clarity of 
messaging, and ease of access to a pharmacist as compared 
to primarily land-based pharmacies that necessitate time-
intensive searches on the part of the consumer to interact 
with the online pharmacy pages. In shaping their standards, 
NABP, FDA and other entities purporting authority for 
recommending quality standards are well advised to 
incorporate long-established industry standards such as the 
U.S Department of Health and Human Services web usability 
guidelines.10  
 
Consistent with Bessell and colleagues’ finding that “e-
pharmacies displaying [privacy statements, information 
disclaimers, and return policies] often placed all the risk and 
responsibilities with the consumer and little with the web site 
operator,” we found the status of medical advice on internet 
pharmacy sites to be questionable. 11  Where a pharmacy is 
linking to external sites for patient education materials, the 
company loses control over the quality, completeness, 
timeliness, and accuracy of the information. The average 
consumer may not have the ability to discern when a link is 
redirecting them to a 3rd party not affiliated with the certified 
online pharmacy. There is likely benefit to patient safety to 
modifying existing VIPPS criteria to include guidelines on the 
inclusion of external links on VIPPS-accredited Internet 
pharmacy sites. 
 
We recommend that VIPPS criteria should include a 
stipulation for online pharmacies to designate a single mailing 
address for patients who are “non-tethered” to a physical 
location. Where online pharmacies are licensed to operate 
within limited geographic locations and where restrictions 
exist, pharmacies should disclose their scope of service so as 
to minimize patient inconvenience due to lost time. A single 
mailing address should be specified for those customers who 
use the online and mail-order services exclusively and/or may 
not have access to a local pharmacy.  
 
Current VIPPS and FDA guidelines fail to address the use of 
social media on online pharmacy sites. Similarly, we did not 
encounter any guidance regarding access via mobile devices. 
Given the increasing ubiquity of mobile devices and their 
acceptance by consumers, future criteria should remedy this 
oversight. 
 
Limitations 
Neither NABP VIPPS criteria nor FDA guidelines mandate a 
uniform design for online pharmacy sites. When searching 
the sites for study-relevant information (e.g., list of pharmacy 
services, state license(s)), we aimed to replicate the 
consumer experience, and limited our navigation to only 
three levels deep. As such, it is possible that we may have 
failed to locate information that is, indeed, offered deeper 
within the web site.  Rather than detract from the 
significance of our study, such potential omissions due to 
navigational choices should serve to underline the 
importance of uniform design criteria. 
 
Conclusion 
As more consumers are tempted to interact with online 
pharmacies, multiple entities offer criteria to guide would-be 
users toward choosing legitimate vendors. However, the very 
legitimacy of recommended criteria remains to be 
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established. Significant opportunities exist to improve the 
quality and scope of existing criteria and to tie them more 
closely to long-standing best-practices in areas such as web 
usability and pharmaceutical care. Future studies should 
focus also on the acceptance of criteria-based decision 
making among consumers as applied to choice of online 
pharmacies.  
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 Table 1: Select VIPPS patient Safety and pharmacy practice standards  
 
Criteria for online pharmacies Source 
 
 
 
 
 
 
 
Web site 
If the pharmacy web site transmits information that 
would be considered Protected Health Information 
(PHI) under the HIPAA Privacy Rule (45 CFR 164), the 
information must be transmitted in accordance with 
HIPAA requirements, including the use of Secure-
Socket Layer or equivalent technology for the 
transmission of PHI, and the pharmacy must display its 
privacy policy that accords with the requirements of 
the HIPAA Privacy Rule. 
VIPPS 
The pharmacy must not engage in practices or extend 
offers on its website that may deceive or defraud 
patients as to any material detail regarding the 
pharmacy, pharmacy staff, prescription drugs, or 
financial transactions. 
VIPPS 
The online pharmacy should provide a physical address 
and telephone number in the United States 
FDA; VIPPS 
The online pharmacy should be licensed through the 
consumer’s state board of pharmacy 
FDA 
 
 
 
 
 
Patient 
services 
The website should allow patients to contact or consult 
with a pharmacist regarding complaints or concerns or 
in the event of a possible adverse event involving their 
medication. 
VIPPS 
The online pharmacy should have a licensed 
pharmacist to answer questions 
FDA 
 
 
 
Table 2: Types of online sites 
 
Types of Online Sites Examples 
Associated with exclusively Internet-based or mail 
order pharmacies (n=12; 33%) 
Healthwarehouse.com 
 
Associated with primarily store-based retail 
pharmacies (n=13; 36%) 
CVS 
Walmart 
Albertsons 
Associated with freestanding / independent 
pharmacies (n=7; 19%) 
Hometown Pharmacy, Inc. 
Association not specified / unclear (n=4; 11%) Foundation Care, LLC 
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Appendix 
Verified Internet Pharmacy Practice Sites (VIPPS) (as of December 23, 2014) 
 
Registrant Web address 
Allcare Specialty Pharmacy, LLC  www.allcarepharmacy.com 
AmeriPharm, Inc dba MedVantx Pharmacy Services www.medvantxrx.com 
Arrow Pharmacy Holdings, LLC 
(Doing business as Arrow Pharmacy and Nutrition Center)  www.Familymeds.com 
BI-LO Holdings, LLC www.winndixie.com www.bi-lo.com 
BioPlus Specialty Pharmacy Services www.bioplusrx.com 
Brawley Pharmacy, Inc 
(Doing business as Valley Medical Pharmacy) www.drugsdepot.com 
BriovaRx, LLC www.briovarx.com 
Curant, Inc www.curanthealth.com 
DrugSource, Inc www.drugsourceinc.com 
drugstore.com www.drugstore.com 
Foundation Care, LLC www.foundcare.com 
Giannotto's Specialty Pharmacy www.giopharm.com 
HealthPartners www.HealthPartners.com 
HealthWarehouse.com www.healthwarehouse.com 
HomeMed Pharmacy, LLC dba PlanTheFam www.homemed.com www.planthefam.com 
Hometown Pharmacy Inc www.hometownpharmacy.com 
HOOK SUPERX, Inc 
(Doing business as CVS/pharmacy) www.cvs.com 
Kmart Corporation www.kmart.com www.mygofer.com  
Liberty Medical Supply, Inc www.libertymedical.com 
Manifest Pharmacy, LLC www.manifestrx.com 
Meijer, Inc www.meijer.com 
New Albertson’s Inc 
www.acmemarkets.com 
www.Albertsons.com 
www.albertsonssavonpharmacies.com 
www.JewelOsco.com 
www.Shaws.com 
North Coast Medical Supply  
(Doing business as Advanced Diabetes Supply) www.northcoastmed.com 
Pillpack, Inc www.pillpack.com 
Ridgeway Pharmacy, Ltd  
(Doing business as Ridgeway Mail Order) www.ridgewayrx.com 
Rx Outreach Inc www.rxoutreach.org 
Tel-Drug, Inc 
(Doing business as Cigna Home Delivery Pharmacy) www.teldrug.com 
Walgreen Co www.walgreens.com 
 
